Title : HCV requires serious policies and affordable insurance coverage
link : HCV requires serious policies and affordable insurance coverage
HCV requires serious policies and affordable insurance coverage
The role of insurance providers in supporting treatment and management of hepatitis C patientsMasoud Behzadifar, Hasan Abolghasem Gorji, Aziz Rezapour, Meysam Behzadifar and Nicola Luigi Bragazzi
https://doi.org/10.1186/s12913-019-3869-8
In order to cope with the high costs of the new DAA regimens, some insurers are restricting access to medications, establishing selective criteria for reimbursement. Gowda and collaborators performed a prospective cohort study among American HCV patients (Open Access Published online 2018 Jun 7). Authors found that absolute denials of DAA regimens by insurers have remained high and increased over time.
Received: 24 April 2018
Accepted: 4 January 2019
Published: 10 January 2019
Full-text article
Read Online
Download PDF
Today, one of the most important global public health challenges is represented by hepatitis C virus (HCV), which imposes relevant costs. Globally speaking, the median cost of HCV-related complications ranges from $280 for an uncomplicated hepatitis to $139,070 for a liver transplantation. There are effective therapies for HCV patients worldwide, which has increased the hope of improving the process of managing and curing these patients. The adherence of patients to the pharmacological treatment and the use of effective drugs in the management of HCV disease are of crucial importance for health policy- and decision-makers. Studies show that, globally, insurance coverage for patients with HCV is not adequate in that still many patients are not covered by insurance programs. This issue as well as the economic conditions of countries are very serious challenges for ensuring an effective treatment. The most important and greatest help currently available to ensure HCV treatment is to implement plans to reduce costs and support patients. Some studies have shown that the expansion of coverage by private payers seems able to generate positive spillover benefits to public insures. Insurers, in addition to maintaining and increasing their own interests, are trying to increase their social status as a sponsor of patients. In conclusion, HCV disease requires serious policies and affordable insurance coverage.
Full-text article
Read Online
Download PDF
Today, one of the most important global public health challenges is represented by hepatitis C virus (HCV), which imposes relevant costs. Globally speaking, the median cost of HCV-related complications ranges from $280 for an uncomplicated hepatitis to $139,070 for a liver transplantation. There are effective therapies for HCV patients worldwide, which has increased the hope of improving the process of managing and curing these patients. The adherence of patients to the pharmacological treatment and the use of effective drugs in the management of HCV disease are of crucial importance for health policy- and decision-makers. Studies show that, globally, insurance coverage for patients with HCV is not adequate in that still many patients are not covered by insurance programs. This issue as well as the economic conditions of countries are very serious challenges for ensuring an effective treatment. The most important and greatest help currently available to ensure HCV treatment is to implement plans to reduce costs and support patients. Some studies have shown that the expansion of coverage by private payers seems able to generate positive spillover benefits to public insures. Insurers, in addition to maintaining and increasing their own interests, are trying to increase their social status as a sponsor of patients. In conclusion, HCV disease requires serious policies and affordable insurance coverage.
Read the full article:
Thus Article HCV requires serious policies and affordable insurance coverage
That's an article HCV requires serious policies and affordable insurance coverage This time, hopefully can give benefits to all of you. well, see you in posting other articles.
You are now reading the article HCV requires serious policies and affordable insurance coverage with the link address https://theleknews.blogspot.com/2019/01/hcv-requires-serious-policies-and.html
0 Response to "HCV requires serious policies and affordable insurance coverage"
Post a Comment